How do we help more people never become patients in the first place?
That may be the single most important question in healthcare.
The future of medicine is not just treating disease earlier. It is helping people avoid disease altogether by giving them the tools, insight, and access to take ownership of their health long before something breaks.
New data presented at the
@ASCO Annual Meeting showed women with a history of GLP-1 use had a 30% lower rate of breast cancer compared to those who had not used these medicines.
A separate study found GLP-1s were associated with a 51% reduction in AML risk in high-risk patients, and up to 74% lower risk in those who had previously received chemotherapy.
These findings do not prove causation. But the signal is becoming too consistent to ignore.
Researchers at
@PennMedicine are now preparing a prospective clinical trial specifically designed to test whether GLP-1s can help prevent breast cancer.
This is exactly what I mean when I talk about offense and defense in our
#healthstack.
Defense is using modern medicines to reduce the probability that disease ever emerges in the first place.
Offense is everything that strengthens us over time: sleep, movement, nutrition, strength, purpose, connection, and the daily behaviors that compound across decades.
The future of healthcare will belong to platforms that combine both. Not waiting for people to become sick but continuously helping them stay well.
We may look back on this era as the moment we shifted from managing disease to leveling up human potential.
medpagetoday.com/meetingcove…